Versiva® XC™

Supports Healing

In a protocol of care for leg ulcers in a non-comparative, 4-week clinical study⁴:

89% of clinicians reported that their patients’ leg ulcers had healed or improved at final evaluation*²	Change in wound condition during use¹
50% decrease in mean wound size from baseline to final evaluation*	Change in wound condition during use¹
Baseline mean wound size (leg ulcer area)⁴ Final evaluations mean wound size (leg ulcer area)⁴	*Using protocols of care that included Versiva® XC™ Gelling Foam Dressing with compression and concomitant medications, including topical steroids and corticosteroids (4.3% of patients), antibiotics and antibacterials (2.2% of patients), and leg ulcer treatments (2.2% of patients)

This page and its content are intended for Australian Healthcare Providers only ConvaTec Australia \| Privacy Statement © 2006 E.R. Squibb & Sons, L.L.C.